Valley National Advisers’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.42K | Buy |
125
+3
| +2% | +$200 | ﹤0.01% | 653 |
|
|
2026
Q1 | $7K | Buy |
122
+2
| +2% | +$139 | ﹤0.01% | 651 |
|
|
2025
Q4 | $7K | Sell |
120
-3
| -2% | -$194 | ﹤0.01% | 657 |
|
|
2025
Q3 | $8K | Sell |
123
-6
| -5% | -$475 | ﹤0.01% | 603 |
|
|
2025
Q2 | $11K | Buy |
129
+5
| +4% | +$392 | ﹤0.01% | 539 |
|
|
2025
Q1 | $8K | Buy |
124
+3
| +2% | +$245 | ﹤0.01% | 589 |
|
|
2024
Q4 | $9K | Buy |
121
+5
| +4% | +$370 | ﹤0.01% | 554 |
|
|
2024
Q3 | $7K | Sell |
116
-152
| -57% | -$12.5K | ﹤0.01% | 557 |
|
|
2024
Q2 | $30K | Buy |
268
+13
| +5% | +$1.64K | ﹤0.01% | 457 |
|
|
2024
Q1 | $35K | Buy |
255
+11
| +5% | +$1.38K | 0.01% | 453 |
|
|
2023
Q4 | $30K | Buy |
244
+103
| +73% | +$10.5K | ﹤0.01% | 480 |
|
|
2023
Q3 | $13K | Sell |
141
-238
| -63% | -$26.8K | ﹤0.01% | 561 |
|
|
2023
Q2 | $49K | Buy |
379
+95
| +33% | +$11.5K | 0.01% | 390 |
|
|
2023
Q1 | $35K | Buy |
284
+14
| +5% | +$1.57K | 0.01% | 437 |
|
|
2022
Q4 | $28K | Buy |
270
+7
| +3% | +$769 | 0.01% | 456 |
|
|
2022
Q3 | $25K | Sell |
263
-1
| -0.4% | -$85 | 0.01% | 466 |
|
|
2022
Q2 | $22K | Sell |
264
-20
| -7% | -$1.82K | ﹤0.01% | 464 |
|
|
2022
Q1 | $37K | Buy |
284
+64
| +29% | +$7K | 0.01% | 427 |
|
|
2021
Q4 | $30K | Buy |
220
+16
| +8% | +$2.3K | 0.01% | 442 |
|
|
2021
Q3 | $28K | Buy |
204
+16
| +9% | +$2.02K | 0.01% | 423 |
|
|
2021
Q2 | $20K | Buy |
188
+12
| +7% | +$1.15K | ﹤0.01% | 481 |
|
|
2021
Q1 | $16K | Buy |
176
+60
| +52% | +$5.63K | ﹤0.01% | 484 |
|
|
2020
Q4 | $11K | Sell |
116
-1,340
| -92% | -$120K | ﹤0.01% | 505 |
|
|
2020
Q3 | $150K | Sell |
1,456
-500
| -26% | -$52.2K | 0.03% | 190 |
|
|
2020
Q2 | $198K | Hold |
1,956
| – | – | 0.05% | 184 |
|
|
2020
Q1 | $132K | Hold |
1,956
| – | – | 0.04% | 191 |
|
|
2019
Q4 | $107K | Hold |
1,956
| – | – | 0.03% | 240 |
|
|
2019
Q3 | $73K | Hold |
1,956
| – | – | 0.02% | 264 |
|
|
2019
Q2 | $73K | Buy |
1,956
+600
| +44% | +$18.9K | 0.02% | 260 |
|
|
2019
Q1 | $40K | Hold |
1,356
| – | – | 0.01% | 301 |
|
|
2018
Q4 | $41K | Hold |
1,356
| – | – | 0.01% | 278 |
|
|
2018
Q3 | $48K | Hold |
1,356
| – | – | 0.02% | 263 |
|
|
2018
Q2 | $32K | Buy |
1,356
+116
| +9% | +$2.46K | 0.01% | 296 |
|
|
2018
Q1 | $23K | Hold |
1,240
| – | – | 0.01% | 318 |
|
|
2017
Q4 | $18K | Sell |
1,240
-740
| -37% | -$9.62K | 0.01% | 341 |
|
|
2017
Q3 | $24K | Hold |
1,980
| – | – | 0.01% | 309 |
|
|
2017
Q2 | $36K | Hold |
1,980
| – | – | 0.01% | 274 |
|
|
2017
Q1 | $42K | Hold |
1,980
| – | – | 0.02% | 254 |
|
|
2016
Q4 | $30K | Hold |
1,980
| – | – | 0.01% | 297 |
|
|
2016
Q3 | $43K | Hold |
1,980
| – | – | 0.02% | 238 |
|
|
2016
Q2 | $39K | Hold |
1,980
| – | – | 0.02% | 253 |
|
|
2016
Q1 | $34K | Buy |
1,980
+540
| +38% | +$9.02K | 0.02% | 258 |
|
|
2015
Q4 | $29K | Hold |
1,440
| – | – | 0.02% | 258 |
|
|
2015
Q3 | $31K | Hold |
1,440
| – | – | 0.02% | 261 |
|
|
2015
Q2 | $29K | Buy |
1,440
+540
| +60% | +$9.48K | 0.02% | 268 |
|
|
2015
Q1 | $14K | Buy |
+900
| New | +$13.6K | 0.01% | 343 |
|
Other funds holding DXCM
Valley National Advisers's DXCM Position: Q2 2026 in Review
Valley National Advisers increased its DexCom (DXCM) stake by 2.5% in Q2 2026, buying an estimated $200 and bringing the position to 125 shares worth $8.42K. The position accounts for ﹤0.01% of the portfolio, ranked #653.
Valley National Advisers first reported a position in DXCM in Q1 2015 and has held it in 46 quarters since. The position peaked at $198K in Q2 2020. 970 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Valley National Advisers held 125 shares of DexCom worth $8.42K as of Q2 2026.
- Valley National Advisers bought 3 DexCom shares in Q2 2026, an estimated $200.
- DexCom made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #653 holding.
- Valley National Advisers first reported a position in DexCom in Q1 2015 and has held it in 46 quarters since.
- Valley National Advisers's DexCom position peaked at $198K in Q2 2020.
- 970 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.